Valuation: Burning Rock Biotech Limited

Market Cap 77Cr 11Cr 10Cr 9.47Cr 8.58Cr 16Cr 1.09TCr 16Cr 112.93Cr 45Cr 574.16Cr 43Cr 42Cr 1.81TCr P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 33Cr 4.92Cr 4.41Cr 4.05Cr 3.67Cr 6.86Cr 467.13Cr 6.99Cr 48Cr 19Cr 245.72Cr 18Cr 18Cr 774.93Cr EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
96.23%
Yield 2024 *
-
Yield 2025 -
1 day-1.36%
1 week-7.78%
Current month-38.17%
1 month-38.17%
3 months+23.16%
6 months-35.88%
Current year-45.91%
1 week 10.29
Extreme 10.29
13.1
1 month 10.29
Extreme 10.29
18
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
176.65
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Date Insider Type Main position Quantity % Market Cap. Importance
31/03/26 Buy

Chief Executive Officer

3,14,870 0.3584%
18/03/26
Northern Light Venture Capital Development Ltd.
OtherCompany 1,18,80,245 13.5213%
17/03/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-7.78%-12.03%+9.00% 12Cr
-0.09%-3.44%+17.68%+32.70% 12TCr
-1.02%+0.89%+1.37%+111.87% 10TCr
-4.98%+2.56%+114.42%+1,003.33% 6.28TCr
-1.84%+9.86%+43.22%+82.37% 2.99TCr
+1.44%+1.95%-6.67%+93.57% 2.96TCr
-0.43%+4.11%+43.28%+94.59% 2.78TCr
+0.99%+1.79%+30.98%+413.15% 2.18TCr
-0.72%+5.53%-18.63%-12.38% 2.07TCr
0.00%-0.63%-4.27%+31.71% 1.71TCr
Average -0.80%+1.37%+20.94%+185.99% 4.29TCr
Weighted average by Cap. -1.04%+1.04%+27.73%+222.86%

Financials

2024 2025
Net sales 52Cr 7.75Cr 6.94Cr 6.38Cr 5.78Cr 11Cr 735.86Cr 11Cr 76Cr 31Cr 387.09Cr 29Cr 28Cr 1.22TCr 54Cr 8.11Cr 7.26Cr 6.68Cr 6.05Cr 11Cr 769.74Cr 12Cr 80Cr 32Cr 404.91Cr 30Cr 30Cr 1.28TCr
Net income -35Cr -5.21Cr -4.66Cr -4.29Cr -3.89Cr -7.27Cr -494.49Cr -7.4Cr -51Cr -21Cr -260.12Cr -20Cr -19Cr -820.31Cr -5.53Cr -83.15L -74.47L -68.5L -62.07L -1.16Cr -79Cr -1.18Cr -8.17Cr -3.28Cr -42Cr -3.12Cr -3.05Cr -130.98Cr
Net Debt -47Cr -7.12Cr -6.37Cr -5.86Cr -5.31Cr -9.93Cr -675.72Cr -10Cr -70Cr -28Cr -355.45Cr -27Cr -26Cr -1.12TCr -44Cr -6.58Cr -5.89Cr -5.42Cr -4.91Cr -9.18Cr -624.38Cr -9.35Cr -65Cr -26Cr -328.44Cr -25Cr -24Cr -1.04TCr
Projected Income Statement - Annual - Burning Rock Biotech Limited
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
30/26/30 $10.90 -1.36% 12,158
29/26/29 $11.05 -9.87% 29,808
28/26/28 $12.26 +3.29% 17,712
27/26/27 $11.87 +6.46% 19,555
26/26/26 $11.15 -5.67% 28,087